MINI-SYMPOSIUM

Free radical production by dysfunctional eNOS

M C Verhaar¹, P E Westerweel¹, A J van Zonneveld², T J Rabelink²

¹ Department of Vascular Medicine, University Medical Center Utrecht, the Netherlands
² Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands

Correspondence to:
Correspondence to:
Marianne C Verhaar, MD, PhD
Department of Vascular Medicine, F02.126, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands; m.c.verhaar{at}azu.nl

Keywords: endothelial nitric oxide synthase; eNOS

Abbreviations: BH4, tetrahydrobiopterin; eNOS, endothelial nitric oxide synthase; FAD, flavin adenine dinucleotide; FMN, flavin mononucleotide; NADPH, nicotinamide adenine dinucleotide phosphate; NO, nitric oxide

The first 150 words of the full text of this article appear below.

Endothelium derived nitric oxide (NO) plays a major role in cardiovascular homeostasis. It has important anti-atherosclerotic properties which include regulation of vasomotor tone and vessel wall permeability, suppression of leucocyte adhesion to the endothelial surface, inhibition of platelet aggregation, and inhibition of vascular smooth muscle cell migration and proliferation. The important role of NO in the cardiovascular system is highlighted by key observations in animal models. Inhibition of endothelial NO synthase (eNOS), the enzyme that catalyses endothelial NO synthesis, accelerates atherogenesis. Similarly, genetic deletion of eNOS in mice leads to hypertension, defective vascular remodelling, vascular thrombosis, and enhanced leucocyte–endothelial cell interactions. In humans, all major cardiovascular risk factors, including hypercholesterolaemia, hypertension, diabetes, and smoking, have been associated with endothelial dysfunction, characterised by impaired NO bioavailability. Importantly, the impairment of NO mediated endothelial function is an independent predictor of adverse cardiac events.¹ Taken together, current data strongly suggest that impaired NO . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Free radicals and redox signalling in cardiovascular disease

A M Shah and K M Channon
Heart 2004 90: 486-487. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Antoniades, C., Shirodaria, C., Leeson, P., Baarholm, O. A., Van-Assche, T., Cunnington, C., Pillai, R., Ratnatunga, C., Tousoulis, D., Stefanadis, C., Refsum, H., Channon, K. M. (2009). MTHFR 677 C>T Polymorphism Reveals Functional Importance for 5-Methyltetrahydrofolate, Not Homocysteine, in Regulation of Vascular Redox State and Endothelial Function in Human Atherosclerosis. Circulation 119: 2507-2515 [Abstract] [Full Text]  
• Balligand, J.-L., Feron, O., Dessy, C. (2009). eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues. Physiol. Rev. 89: 481-534 [Abstract] [Full Text]  
• Lu, Y.-M., Han, F., Shioda, N., Moriguchi, S., Shirasaki, Y., Qin, Z.-H., Fukunaga, K. (2009). Phenylephrine-Induced Cardiomyocyte Injury Is Triggered by Superoxide Generation through Uncoupled Endothelial Nitric-Oxide Synthase and Ameliorated by 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxyindazole (DY-9836), a Novel Calmodulin Antagonist. Mol. Pharmacol. 75: 101-112 [Abstract] [Full Text]  
• Seddon, M., Looi, Y. H, Shah, A. M (2007). Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93: 903-907 [Abstract] [Full Text]  
• Thum, T., Fraccarollo, D., Schultheiss, M., Froese, S., Galuppo, P., Widder, J. D., Tsikas, D., Ertl, G., Bauersachs, J. (2007). Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes. Diabetes 56: 666-674 [Abstract] [Full Text]  
• Yokoyama, M., Hirata, K.-i. (2007). Endothelial nitric oxide synthase uncoupling: Is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery?. Cardiovasc Res 73: 8-9 [Full Text]